Skip to main content
OpenTrials

Clinical trial condition

Duchenne Muscular Dystrophy

Explore clinical trials studying Duchenne Muscular Dystrophy. Study availability and eligibility vary by location and protocol.

216 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Duchenne Muscular Dystrophy trial results

Not yet recruiting

The U.K. NorthStar Clinical Network

NCT06711692

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Aberdeen, NHS Grampian Aberdeen, United Kingdom
  • Belfast Health and Social Care Trust Belfast, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Birmingham Community Healthcare NHS Foundation Trust Birmingham, United Kingdom
View all 26 locations
View Trial Details
Not yet recruiting

Development of a Registry to Assess Natural History in Duchenne Muscular Dystrophy

NCT06579859

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • ASL LANCIANO VASTO CHIETI, Laboratorio di Patologie Neuromuscolari del Centro di Riferimento Regionale per le Malattie Neuromuscolari Chieti, Ch, Italy
  • ASST Grande Ospedale Metropolitano Niguarda, Centro Clinico Nemo Milano Milan, MI, Italy
  • Azienda Ospedaliera Universitaria "G. Martino"UOC di Neurologia e Malattie Neuromuscolari Messina, Italy
  • Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC NEMO Pediatrico Roma, Italy
View Trial Details
Enrolling by invitation

An Observational Study Comparing Delandistrogene Moxeparvovec (ELEVIDYS) With Standard of Care in Participants With Duchenne Muscular Dystrophy

NCT06270719

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles - PIN Los Angeles, California, United States
  • University of Colorado - PPDS Aurora, Colorado, United States
  • Connecticut Children's Medical Center - Hartford Hartford, Connecticut, United States
View all 25 locations
View Trial Details
Enrolling by invitation

Long Term Follow-up for RGX-202

NCT06491927

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford School of Medicine /Division of Neuromuscular Medicine Palo Alto, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • The University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Enrolling by invitation

Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy

NCT07209332

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Istiklal Hospital/ Clinical Research Unit Amman, Jordan
  • The Specialty Hospital (TSH)/ Advanced Clinical Center Amman, Jordan
  • Oxford Children's Hospital, Oxford University Hospitals NHS Foundation Trust Headington, Oxford, United Kingdom
View Trial Details
Enrolling by invitation

A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study

NCT05967351

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford (LPCH) Palo Alto, California, United States
  • University of California, Davis Sacramento, California, United States
View all 38 locations
View Trial Details

Related conditions